Kenya Multisite Integrated Surveillance of COVID-19 and Other Pathogens, KEMIS I

Kenya, 2022
Health and Well-Being (HaW)

Dr. Abdhalah Ziraba

CSV JSON

Second COVID vaccine type (q16a_covid_vaccine_type2)

Data file: Kemis Phase 1

Overview

vald 181

invd 670

Interval discrete

Decimal 0

Range 1 - 98

Questions and instructions

Literal question

16.2 COVID vaccine type? (1 - AstraZeneca, 2 - Pfizer, 3- Johnson & Johnson, 4 -Moderna, 5 -SputnikV, 6-Sinopharm 7- Others….(specify))

Categories

Value	Category	Cases
1	AstraZeneca	90	49.7%
2	Pfizer	28	15.5%
3	Johnson & Johnson	0	0%
4	Moderna	28	15.5%
5	SputnikV	0	0%
6	Sinopharm	1	0.6%
96	Other vaccine	0	0%
98	don't know	34	18.8%
Sysmiss		670

Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.

Question pretext

Question post text

Interviewer instructions

Description

Text

Type received on second dose

Universe

NUHDSS residents